22nd Century ROA 2011-2023 | XXII
Current and historical return on assets (ROA) values for 22nd Century (XXII) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| 22nd Century ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-09-30 |
$-0.14B |
$0.06B |
-128.97% |
| 2023-06-30 |
$-0.08B |
$0.13B |
-61.66% |
| 2023-03-31 |
$-0.07B |
$0.12B |
-54.40% |
| 2022-12-31 |
$-0.06B |
$0.12B |
-53.39% |
| 2022-09-30 |
$-0.05B |
$0.14B |
-46.65% |
| 2022-06-30 |
$-0.04B |
$0.12B |
-49.57% |
| 2022-03-31 |
$-0.04B |
$0.07B |
-44.31% |
| 2021-12-31 |
$-0.03B |
$0.08B |
-40.13% |
| 2021-09-30 |
$-0.02B |
$0.09B |
-32.54% |
| 2021-06-30 |
$-0.02B |
$0.10B |
-28.57% |
| 2021-03-31 |
$-0.02B |
$0.06B |
-34.78% |
| 2020-12-31 |
$-0.02B |
$0.05B |
-32.48% |
| 2020-09-30 |
$-0.02B |
$0.06B |
-30.28% |
| 2020-06-30 |
$-0.03B |
$0.06B |
-39.06% |
| 2020-03-31 |
$-0.03B |
$0.06B |
-42.11% |
| 2019-12-31 |
$-0.03B |
$0.07B |
-37.28% |
| 2019-09-30 |
$-0.03B |
$0.06B |
-40.42% |
| 2019-06-30 |
$-0.01B |
$0.07B |
-16.72% |
| 2019-03-31 |
$-0.01B |
$0.08B |
-15.05% |
| 2018-12-31 |
$-0.01B |
$0.08B |
-11.08% |
| 2018-09-30 |
$-0.00B |
$0.09B |
-4.88% |
| 2018-06-30 |
$-0.01B |
$0.08B |
-18.98% |
| 2018-03-31 |
$-0.01B |
$0.08B |
-16.07% |
| 2017-12-31 |
$-0.01B |
$0.08B |
-31.33% |
| 2017-09-30 |
$-0.01B |
$0.03B |
-42.11% |
| 2017-06-30 |
$-0.01B |
$0.03B |
-47.06% |
| 2017-03-31 |
$-0.01B |
$0.03B |
-52.75% |
| 2016-12-31 |
$-0.01B |
$0.03B |
-55.17% |
| 2016-09-30 |
$-0.01B |
$0.02B |
-62.34% |
| 2016-06-30 |
$-0.01B |
$0.02B |
-61.54% |
| 2016-03-31 |
$-0.01B |
$0.02B |
-48.19% |
| 2015-12-31 |
$-0.01B |
$0.02B |
-55.00% |
| 2015-09-30 |
$-0.01B |
$0.02B |
-66.67% |
| 2015-06-30 |
$-0.01B |
$0.02B |
-62.22% |
| 2015-03-31 |
$-0.02B |
$0.02B |
-76.92% |
| 2014-12-31 |
$-0.02B |
$0.02B |
-88.89% |
| 2014-09-30 |
$-0.02B |
$0.03B |
-116.13% |
| 2014-06-30 |
$-0.03B |
$0.01B |
-307.69% |
| 2014-03-31 |
$-0.03B |
$0.01B |
-361.29% |
| 2013-12-31 |
$-0.03B |
$0.01B |
-472.73% |
| 2013-09-30 |
$-0.02B |
$0.00B |
-676.92% |
| 2013-06-30 |
$-0.01B |
$0.00B |
-233.33% |
| 2013-03-31 |
$-0.01B |
$0.00B |
-233.33% |
| 2012-12-31 |
$-0.01B |
$0.00B |
-218.18% |
| 2012-09-30 |
$-0.00B |
$0.00B |
-40.00% |
| 2012-06-30 |
$-0.00B |
$0.00B |
-44.44% |
| 2012-03-31 |
$-0.00B |
$0.00B |
-88.89% |
| 2011-12-31 |
$-0.00B |
$0.00B |
-40.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.006B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
